Anthony Martinelli

Anthony Martinelli is Founder and Editor-in-Chief of The Marijuana Herald, a daily marijuana news and information website that launched in 2018. You can reach Anthony at [email protected].

Author's posts

Arizona Court Rules Driver’s Licenses Can’t Be Suspended Solely for Marijuana in Blood

The Arizona Court of Appeals ruled today that merely having marijuana in a driver’s system is insufficient for the state to suspend their license. The court dismissed arguments from the Motor Vehicle Division (MVD) that a blood test showing marijuana metabolites constituted sufficient evidence of being “under the influence.” Appellate Judge Andrew Jacobs, writing for …

Continue reading

Oregon Marijuana Sales Top $75 Million for 20th Straight Month

August marked the 20th consecutive month where Oregon’s legal marijuana sales were above $75 million. Data compiled and released by the Oregon Liquor and Cannabis Commission shows that there was $78,565,729 worth of marijuana sold legally in August, a roughly $5 million decrease from the $84 million sold in July. All-time sales are now over …

Continue reading

Public Hearing on Marijuana Rescheduling Will Take Place in Two Months on December 2

The public hearing for the Drug Enforcement Administration’s (DEA) proposal to reschedule marijuana from Schedule I, to Schedule III, will take place in exactly two months, on December 2. “This is notice that the Drug Enforcement Administration will hold a hearing with respect to the proposed rescheduling of marijuana into schedule III of the Controlled …

Continue reading

Study Says Nanotechnology Could Revolutionize Marijuana-Based Medicine

A new study published in the journal Recent Advances in Drug Delivery and Formulation suggests that nanotechnology could be key to overcoming the challenges of effectively administering cannabis-based medicines. Conducted by researchers from the University of Michigan and the University at Buffalo, the study explores how nanotechnology could improve the bioavailability, solubility, and targeted delivery …

Continue reading

Illinois Marijuana Company Launches “Doobies for Boobies” Fundraiser to Support Breast Cancer Awareness Month

 nuEra, a leading cannabis brand, says it’s “proud to announce the launch of its “Doobies for Boobies” Breast Cancer Awareness (BCA) fundraiser to support Gilda’s Club, a nonprofit organization that provides free programs to support individuals impacted by cancer.” Running from October 1st to 31st, nuEra will donate $1 from every sale of its BCA pre-rolls and …

Continue reading

Next Month Three Texas Cities Will Vote on Marijuana Decriminalization Proposals

On November 5, voters in three Texas cities have the opportunity to join a handful of others that have decriminalized marijuana possession. During the November 2022 election, voters in five cities —San Marcos, Austin, Denton, Fort Hood, and Elgin— approved ordinances to decriminalize marijuana, with support ranging between 60% and 82%. This November, voters in …

Continue reading

New Hampshire Committee to Vote Next Week on Legislation to Legalize Psychedelics for Therapeutic Use

A committee in the New Hampshire House of Representative is expected to vote next week on a bill that would legalize the therapeutic use of certain psychedelics. House Bill 1693, filed in December by State Representative Kevin Verville (R), would require the Department of Health and Human Services to create and administer a new program …

Continue reading

New Mexico Marijuana Sales Top $50 Million in September, Nearly $400 Million So Far in 2024

For the fifth time this years, monthly marijuana sales in New Mexico passed $50 million. There was $50,097,212.57 worth of marijuana and marijuana products sold legally in New Mexico in August, according to the state’s Regulation & Licensing Department. Adult-use sales for August were $38,018,830.10, with medical marijuana sales making up the other $12,078,382.44. There …

Continue reading

NORML Files Notice of Intent to Participate in DEA’s December 2 Hearing on Marijuana Rescheduling

Yesterday, NORML filed a Notice of Appearance and Notice of Intent to Participate in the upcoming DEA hearing on marijuana rescheduling, which will take place on December 2. In its filings, NORML maintained that its “representation of its members and millions of other cannabis consumers, combined with its historical involvement and expertise, makes it uniquely …

Continue reading

Congressional Lawmakers Urge DEA to Finalize Proposal to Reschedule Marijuana to Schedule III

House Judiciary Committee Ranking Member Jerrold Nadler (D-NY) and Energy and Commerce Committee Ranking Member Frank Pallone, Jr. (D-NJ) sent a letter today to the Drug Enforcement Administration (DEA) urging them to move swiftly on implementing their proposed rule to transfer marijuana from schedule I to schedule III of the Controlled Substances Act (CSA). The …

Continue reading